The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; AstraZeneca (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); MSD Oncology; Pfizer
Second-line nintedanib plus docetaxel for patients with lung adenocarcinoma after failure on first-line immune checkpoint inhibitor combination therapy: Initial efficacy and safety results from VARGADO Cohort C.
 
Christian Grohé
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD Oncology; Novartis; Roche; Takeda
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD Oncology
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Roche
 
Thomas Wehler
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Roche/Genentech
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche/Genentech
Research Funding - AstraZeneca; Boehringer Ingelheim; Roche/Genentech
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Celgene; Pfizer; Roche/Genentech
 
Tobias Dechow
No Relationships to Disclose
 
Sven Henschke
Consulting or Advisory Role - Boehringer Ingelheim; Chugai Pharma
Research Funding - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim
 
Wolfgang Schuette
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Roche
Research Funding - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck; Novartis; ose pharma; Roche
Other Relationship - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
 
Ina Dittrich
No Relationships to Disclose
 
Stefan Hammerschmidt
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; MSD; Roche
 
Harald Müller-Huesmann
Honoraria - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; MSD; Roche
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; MSD; Roche
Speakers' Bureau - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; MSD; Roche
Expert Testimony - Roche
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Janssen; Merck; MSD; Roche
 
Christian Schumann
No Relationships to Disclose
 
Stefan Krüger
Honoraria - Boehringer Ingelheim; Boehringer Ingelheim (Inst)
 
Judith Atz
Employment - Boehringer Ingelheim
 
Rolf Kaiser
Employment - Boehringer Ingelheim
Patents, Royalties, Other Intellectual Property - Boehringer Ingelheim (Inst)